W
Wave Life Sciences Ltd. (WVE)
NGM – Real Time Price. Currency in USD
6.79
-0.28 (-3.96%)
At close: May 12, 2026, 4:00 PM EDT
6.89
+0.10 (1.47%)
After-hours: May 12, 2026, 7:05 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
6.79
-0.28 (-3.96%)
At close: May 12, 2026, 4:00 PM EDT
6.89
+0.10 (1.47%)
After-hours: May 12, 2026, 7:05 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 11.26 | 6.05 | 10 | |
| Quick ratio | 11.26 | 5.63 | 10 | |
| Debt to Equity | 0.03 | 0.30 | 9.0 | |
| Debt to Assets | 0.03 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 4M | 113M | 108M | 43M | 72M |
| Gross Profit | -6M | 104M | 100M | 34M | 63M |
| Operating Income | -163M | -68M | -110M | -215M | -197M |
| Net Income | -162M | -58M | -97M | -204M | -184M |
| EBITDA | -153M | -59M | -102M | -207M | -188M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -11.99 | 2.35 | 2.0 |
| Next quarter | -1.19 | 1.17 | 2.0 |
| Current year | 35.19 | 8.1 | 8.0 |
| Next year | -2.57 | -16.37 | 1.0 |
| Weighted average score | 3.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 121.78 | 50.94 | 56.67 | -86.8 | 7.8 |
| Y/Y | 316.85 | 44.35 | 55.17 | 5.08 | 8.8 |
| 3y average | 980.05 | -38.28 | -9.59 | -193.11 | 3.3 |
| 5y average | 590.62 | -25.75 | 4.51 | -119.97 | 4.0 |
| Weighted average score | 6.0 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $544.6M significantly exceed its total debt $15.7M, ensuring strong financial flexibility
Total current assets $561.3M exceed Total current liabilities $49.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$60.0M limits the company's ability to reinvest or pay down debt